23.711.13% ( -0.27 )
Delay Trading: Nov 16, 11:21:54Valuation
Current ValuationThe current P/E ratio is 65.30, within the reasonable range, cheaper than 30.73% of the time in the past 3 years, and the industry ranks 120/222, the industry Median 22.14.
65.3xP/E
¥23.98Stock price
¥0.37Earnings per share
65.3xP/E
Stock price¥23.98Earnings per share¥0.37
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 57.01x
- Typical range
- 35.79x–71.31x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 22.14x
017345168
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 22.14x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
300558SZBETTA PHARMACEUTICALS | 71.31x | 25.34% | ¥19.02B |
002399SZHepalink | 70.35x | 80.52% | ¥13.35B |
300723SZApicHope | 70.75x | 255.12% | ¥12.80B |
300049SZFurui Co.,Ltd. | 65.16x | 75.86% | ¥11.47B |
002755SZASK PHARM | 62.04x | -- | ¥11.33B |
603538SHMenovo | 63.14x | -- | ¥6.97B |
002728SZTY PHAR. | 71.03x | 181.25% | ¥4.68B |
600628SHSNW | 69.75x | -- | ¥4.11B |
002644SZFoci Pharmaceutical | 60.61x | -- | ¥3.75B |
600222SHTaloph | 69.77x | -- | ¥3.55B |
301509SZKingchem | 68.86x | -- | ¥3.11B |
301331SZENWEI PHARMACEUTICAL | 65.30x | -- | ¥2.47B |
603079SHSHENGDA BIO-PHARM | 63.61x | -- | ¥2.16B |
300583SZSito Bio | 72.31x | -- | ¥2.10B |
002566SZYISHENG PHARM | 75.67x | -- | ¥1.98B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
